Top Markets
Coin of the day
Delta-Fly Pharma, Inc. Delta-Fly Pharma, Inc.

Delta-Fly Pharma, Inc.

4598
Peringkat dalam Saham #32530
Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a... Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a biotechnology company focused on the development of innovative oncology drugs. Their comprehensive pipeline includes several drug candidates targeting various cancers. DFP-10917 is currently undergoing Phase III clinical evaluation in the United States and Phase I in Japan for relapsed/refractory acute myeloid leukemia. Another significant compound, DFP-14323, is in Phase III trials for lung cancer. The firm is also advancing DFP-17729 through Phase I/II studies for solid tumors. Furthermore, DFP-11207 has successfully completed its Phase I clinical trial for pancreatic cancer. For hematologic malignancies, DFP-14927 is in Phase I, while DFP-10825 is in preclinical development, targeting gastric and ovarian cancers.
Harga Saham
$0.69158324
Kapitalisasi Pasar
$9.84M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-84.15%
Negara
JP
Perdagangan Delta-Fly Pharma, Inc. (4598)

Kategori

Riwayat harga saham Delta-Fly Pharma, Inc. (4598)
Harga penutupan tertinggi: $0.69 pada 2026-08-01

Harga penutupan terendah: $3.99 pada 2024-07-01
Riwayat harga saham Delta-Fly Pharma, Inc. dari 2024 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -37.60%
2025 -13.51%
2024 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$515.58 31.26%
US
$992.01 51.72%
NL
$736.64 7.19%
CH
$1.07K -6.40%
KR
$255.50 13.38%
BE